TrialJournal of acquired immune deficiency syndromes (1999)2018

Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results From NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine or Raltegravir.

Elizabeth C George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.